FDA — authorised 22 March 2016
- Application: BLA125521
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: TALTZ
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Taltz on 22 March 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 March 2016; FDA has authorised it.
ELI LILLY AND CO holds the US marketing authorisation.